Clinical Trial Update: A Hepatic Impairment Study for PF-04965842. [Phase 1]

View source ↗

Summary

Phase 1 hepatic impairment study for PF-04965842 completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Impairment

Drugs mentioned

• PF-04965842

Snippet

Sponsor: Pfizer | Conditions: Hepatic Impairment | Phase 1 | Status: COMPLETED | Results posted: 2020-05-18